Page last updated: 2024-08-21

vancomycin and carbostyril

vancomycin has been researched along with carbostyril in 51 studies

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's26 (50.98)18.2507
2000's13 (25.49)29.6817
2010's10 (19.61)24.3611
2020's2 (3.92)2.80

Authors

AuthorsStudies
Fenoll, A; López de Felipe, F; Martínez-Suárez, JV; Rodríguez-Tudela, JL1
Watanabe, A1
Appelbaum, PC; Jacobs, MR; Spangler, SK1
Handwerger, S; Mildvan, D; Shonekan, D2
Bailey, EM; Kaatz, GW; Lamp, KC; Rybak, MJ; Seo, SM1
Cars, O; Löwdin, E; Odenholt-Tornqvist, I1
Kanno, H1
Hessen, MT; Kaye, D; Pitsakis, PG1
Cagni, A; Chuard, C; Lew, DP; Schrenzel, J; Vaudaux, PE1
Carbon, C; Cochereau, I; Marrakchi-Benjaafar, S; Pocidalo, JJ1
Giamarellou, H1
Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A1
Appelbaum, PC; Jacobs, MR; Pankuch, GA1
Hiramatsu, K; Hori, S1
Tsuji, A1
Ehrett, S; Friedland, IR; Hickey, S; McCracken, GH; Olsen, K; Paris, M1
Arai, T; Kinoshita, T; Nimura, N1
Appelbaum, PC; Jacobs, MR; Visalli, MA1
Herrera-Insúa, I; Jacques-Palaz, K; Murray, BE; Rakita, RM1
Biedenbach, DJ; Johnson, DM; Jones, RN; Marshall, SA1
Hoban, DJ; Karlowsky, JA; Zhanel, GG1
Frimodt-Møller, N; Knudsen, JD; Ostergaard, C; Sørensen, TK1
Blard, JM; Finiels, PJ; Khoris, J; Milhaud, D; Pagès, M; Privat, JM1
Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR1
Hatanaka, K; Hiraoka, A; Hosen, N; Karasuno, T; Kawamoto, S; Masaoka, T; Nakamura, H; Nakao, T; Teshima, H; Ujiie, H; Yagi, T1
Bonner, D; Fung-Tomc, J; Gradelski, E; Kolek, B; Valera, L1
Ghaffar, F; Hardy, RD; Iglehart, J; McCracken, GH; Michelow, IC; Olsen, K; Rodriguez-Cerrato, V; Saavedra, J1
Ferber, D1
Barton, T; Bowlware, K; Hardy, RD; Iglehart, J; Katz, K; McCoig, CC; McCracken, GH; Michelow, IC; Rodriguez-Cerrato, V; Saavedra, J1
Lowy, FD1
Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Miyazaki, Y; Murata, I; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K1
Jones, RN; Kirby, JT; Sader, HS; Walsh, TR1
Di, JH; Shen, XZ; Yang, YH1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Flatz, L; Kühn, F; Müller, HP; Pfister, M; Stucki, A1
Brøsen, K; Frimodt-Møller, N; Gahrn-Hansen, B; Madsen, H1
Higashiyama, Y; Hirakata, Y; Izumikawa, K; Kohno, S; Miyazaki, Y; Mizuta, Y; Seki, M; Tomono, K; Tsukamoto, K; Yanagihara, K1
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H1
Appelbaum, PC; Credito, K; Lin, G1
Galanakis, E; Maraki, S; Samonis, G1
Medico, CJ; Walsh, P1
Fondelli, S; Iacopi, E; Leonildi, A; Menichetti, F; Piaggesi, A; Rizzo, L; Tagliaferri, E; Tascini, C; Tedeschi, A1
Dasgupta, A1
Akamatsu, Y; Baba, T; Hiramatsu, K; Igarashi, M; Morimoto, Y; Umekita, M1
Leggio, M; Podos, SD; Pucci, MJ; Thanassi, JA1
Deierhoi, RJ; Graham, LA; Hawn, MT; Henderson, WG; Itani, KM; Richman, JS; Vick, CC1
Baud, D; Greub, G; Vouga, M1
Awosile, B; German, G; Heider, LC; McClure, JT; Rodriguez-Lecompte, JC; Saab, ME1
Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G1
ALanazi, AG; Ali, I; ALOthman, ZA; Suhail, M1
Peters, AT; Pickens, CI; Postelnick, MJ; Qi, C; Wunderink, RG; Zembower, TR1

Reviews

8 review(s) available for vancomycin and carbostyril

ArticleYear
Empiric therapy for infections in the febrile, neutropenic, compromised host.
    The Medical clinics of North America, 1995, Volume: 79, Issue:3

    Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Immunocompromised Host; Lactams; Mycoses; Neutropenia; Quinolones; Sulfamethoxazole; Time Factors; Trimethoprim; Vancomycin; Virus Diseases

1995
[Gram-positive cocci (include MRSA)].
    Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52, Issue:2

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

1994
Antimicrobial resistance: the example of Staphylococcus aureus.
    The Journal of clinical investigation, 2003, Volume: 111, Issue:9

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Humans; Penicillins; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2003
[Progresses in molecular biologic studies on coagulase negative staphylococcus infection].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2004, Volume: 42, Issue:1

    Topics: Bacteremia; Catheterization; Child; Coagulase; Cross Infection; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Methicillin; Quinolones; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections; Vancomycin

2004
[Antibiotics and overweight].
    Ugeskrift for laeger, 2005, May-23, Volume: 167, Issue:21

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Body Weight; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Obesity; Penicillins; Quinolones; Vancomycin

2005
Pharmacotherapy in the critically ill obese patient.
    Critical care clinics, 2010, Volume: 26, Issue:4

    Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin

2010
Advances in antibiotic measurement.
    Advances in clinical chemistry, 2012, Volume: 56

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Cephalosporins; Chloramphenicol; Chromatography; Humans; Immunoassay; Macrolides; Penicillins; Quinolones; Sulfonamides; Vancomycin

2012
Risk factors for hospitalized patients with resistant or multidrug-resistant
    Antimicrobial resistance and infection control, 2018, Volume: 7

    Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin

2018

Trials

1 trial(s) available for vancomycin and carbostyril

ArticleYear
[New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Intestines; Middle Aged; Quinolones; Sterilization; Tobramycin; Transplantation Conditioning; Vancomycin

1999

Other Studies

42 other study(ies) available for vancomycin and carbostyril

ArticleYear
Comparative in-vitro activity of four peptide antibiotics against penicillin-resistant Streptococcus pneumoniae isolated from cerebrospinal fluid (CSF).
    The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cerebrospinal Fluid; Daptomycin; Erythromycin; Fluoroquinolones; Glycopeptides; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Quinolones; Serotyping; Streptococcus pneumoniae; Teicoplanin; Vancomycin

1992
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
    Nihon Kyobu Shikkan Gakkai zasshi, 1992, Volume: 30, Issue:2

    Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin

1992
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:4

    Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin

1992
Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Depsipeptides; Enterococcus faecalis; Fluoroquinolones; Glycopeptides; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin

1992
CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:6

    Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Fluoroquinolones; Kidney; Male; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Rabbits; Spleen; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1992
Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolones; Roxithromycin; Streptococcus pneumoniae; Streptococcus pyogenes; Vancomycin

1992
[Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
    Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Disinfectants; Humans; Lactams; Macrolides; Methicillin Resistance; Postoperative Complications; Quinolones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines; Vancomycin

1990
Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:6

    Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Fluoroquinolones; Male; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin

1990
Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Foreign Bodies; Guinea Pigs; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1995
Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
    The Journal of infectious diseases, 1995, Volume: 172, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Eye; Eye Infections, Bacterial; Female; Fluoroquinolones; Imipenem; Pefloxacin; Quinolones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1995
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
    Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin

1995
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:9

    Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin

1994
[Mechanisms of antimicrobial resistance].
    Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Lactams; Macrolides; Methicillin Resistance; Quinolones; Staphylococcus aureus; Vancomycin

1994
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Rifampin; Thienamycins; Vancomycin

1993
Investigation of enantioselective separation of quinolonecarboxylic acids by capillary zone electrophoresis using vancomycin as a chiral selector.
    Journal of chromatography. A, 1996, Jun-07, Volume: 736, Issue:1-2

    Topics: Anti-Infective Agents; Electrophoresis, Capillary; Fluoroquinolones; Ofloxacin; Quinolones; Stereoisomerism; Vancomycin

1996
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cell Division; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae; Thienamycins; Time Factors; Vancomycin

1996
Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neutrophils; Quinolones; Vancomycin; Virginiamycin

1996
Activity of two novel fluoroquinolones (DU-6859a and DV-7751a) tested against glycopeptide-resistant enterococcal isolates.
    Diagnostic microbiology and infectious disease, 1995, Volume: 23, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; Vancomycin

1995
Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Quinolones; Teicoplanin; Tetracyclines; Vancomycin; Virginiamycin

1997
In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species.
    Diagnostic microbiology and infectious disease, 1998, Volume: 31, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Canada; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Vancomycin

1998
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Drug Evaluation; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Protein Binding; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Time Factors; Vancomycin

1998
[Epidural and intramedullary abscess of acute onset].
    Revue neurologique, 1998, Volume: 154, Issue:2

    Topics: 4-Quinolones; Abscess; Anti-Infective Agents; Drug Therapy, Combination; Epidural Space; Fluoroquinolones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oxacillin; Pefloxacin; Quinolones; Spinal Cord Diseases; Vancomycin

1998
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin

1999
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
    International journal of antimicrobial agents, 2001, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactams; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Indoles; Kinetics; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus; Vancomycin

2001
BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporin Resistance; Fluoroquinolones; Indoles; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Vancomycin

2001
Antibiotic resistance. Livestock feed ban preserves drugs' power.
    Science (New York, N.Y.), 2002, Jan-04, Volume: 295, Issue:5552

    Topics: Animal Feed; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Europe; Feces; Fluoroquinolones; Glycopeptides; Humans; Quinolones; Swine; United States; United States Food and Drug Administration; Vancomycin; Vancomycin Resistance; Virginiamycin

2002
Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:1

    Topics: Animals; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Indoles; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance

2003
Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-caused hematogenous pulmonary infections in mice.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Blood-Borne Pathogens; Injections, Intraperitoneal; Lung; Lung Diseases; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance

2003
Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).
    Journal of clinical microbiology, 2004, Volume: 42, Issue:1

    Topics: Anti-Infective Agents; beta-Lactam Resistance; Chryseobacterium; Humans; Microbial Sensitivity Tests; Quinolones; Vancomycin

2004
Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Kinetics; Meninges; Meningitis, Pneumococcal; Mutation; Penicillin Resistance; Quinolones; Rabbits; Streptococcus pneumoniae; Vancomycin

2004
Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Lung; Male; Methicillin; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Pyrrolidines; Quinolones; Specific Pathogen-Free Organisms; Staphylococcus aureus; Vancomycin

2006
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:3

    Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin

2006
Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pyrrolidines; Quinolones; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin

2007
Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11

    Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Chloramphenicol; Clindamycin; Greece; Heptavalent Pneumococcal Conjugate Vaccine; History, 21st Century; Humans; Immunization Programs; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Pneumococcal Vaccines; Quinolones; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vaccines, Conjugate; Vancomycin

2010
Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.
    Diabetes research and clinical practice, 2011, Volume: 94, Issue:1

    Topics: Anti-Infective Agents; Candida; Diabetic Foot; Doxycycline; Enterococcus; Enterococcus faecalis; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolones; Rifampin; Staphylococcus aureus; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2011
Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:6

    Topics: Anti-Bacterial Agents; DNA Gyrase; Drug Resistance, Bacterial; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Quinolones; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2012
Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7

    Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Quinolines; Quinolones; Rifampin; Staphylococcus; Thiazoles; Vancomycin

2012
Timing of surgical antibiotic prophylaxis and the risk of surgical site infection.
    JAMA surgery, 2013, Volume: 148, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cefazolin; Digestive System Surgical Procedures; Female; Humans; Hysterectomy; Male; Middle Aged; Quinolones; Retrospective Studies; Risk Factors; Surgical Wound Infection; Time Factors; Vancomycin; Vascular Surgical Procedures

2013
Simkania negevensis, an Example of the Diversity of the Antimicrobial Susceptibility Pattern among Chlamydiales.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cell Line; Chlamydiaceae Infections; Chlamydiales; Chlorocebus aethiops; Clindamycin; Macrolides; Microbial Sensitivity Tests; Quinolones; Rifampin; Vancomycin; Vero Cells

2017
Determination of antimicrobial resistance to extended-spectrum cephalosporin, quinolones, and vancomycin in selected human enteric pathogens from Prince Edward Island, Canada.
    Canadian journal of microbiology, 2018, Volume: 64, Issue:7

    Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Humans; Prince Edward Island; Quinolones; Vancomycin

2018
HPLC enantio-separation and chiral recognition mechanism of quinolones on vancomycin CSP.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020, Nov-10, Volume: 1157

    Topics: Chromatography, High Pressure Liquid; Limit of Detection; Linear Models; Quinolones; Reproducibility of Results; Stereoisomerism; Vancomycin

2020
Decreasing incidence of
    Infection control and hospital epidemiology, 2022, Volume: 43, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Vancomycin

2022